Uridine Related Compound 1(CAS: 122567-97-9)

Uridine Related Compound 1 (CAS: 122567-97-9) falls under the scope of the GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for hazardous substances. It must comply with REACH regulations in the European Union, which require registration and reporting of substances above one tonne per year. In the United States, it is regulated by the FDA for pharmaceutical applications and by the EPA for environmental and safety standards.

Alternatives to Uridine Related Compound 1 (CAS: 122567-97-9) in synthesis include related nucleosides and analogs such as thymidine or adenosine. Other common reagents used in synthesis include cytidine and other uridine derivatives. These alternatives can serve as effective substitutes based on specific reaction requirements and desired product properties.

The market for Uridine Related Compound 1 (CAS: 122567-97-9) is primarily driven by its applications in pharmaceuticals, particularly in the development of antiviral and anticancer drugs. Research trends focus on exploring its potential in gene therapy and RNA interference. The compound is also used in biological research for studying nucleotide metabolism and DNA synthesis. Market trends show increasing demand from academic and industrial research sectors.

Waste containing Uridine Related Compound 1 (CAS: 122567-97-9) should be collected in appropriate containers and stored safely to prevent environmental contamination. For small-scale waste, incineration is an effective method. For larger quantities, professional waste disposal services should be utilized. It is essential to follow local regulations and guidelines for the safe disposal of hazardous chemicals, including proper labeling and documentation of waste material. Environmental protection measures, such as Minimization and Recycling, should be prioritized to reduce the overall impact on the environment.